Please check your internet connection and try again.
## Sodium Phosphate Enema
### Overview
Sodium phosphate enema is a hypertonic saline solution used as a saline laxative and evacuant for bowel preparation.
### Primary Indications
* Bowel preparation prior to colonoscopy or surgery.
* Relief of occasional constipation.
### Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) bottle administered rectally as a single dose. For some protocols, a second dose may be administered a specified time before the procedure. *Refer to specific institutional or procedural guidelines for exact timing and regimen.*
* **Constipation:** One 2.25 oz (66 mL) bottle administered rectally as a single dose. Maximum frequency is typically once every 24 hours.
### Pediatric Dosing
* **Children 5 years and older:** Typically, one 2.25 oz (66 mL) bottle administered rectally as a single dose.
* **Children younger than 5 years:** Use is generally not recommended due to increased risk of adverse effects. If used, it should be under strict medical supervision. *Consult with a pediatrician for specific dosing if necessary.*
### Dose Adjustments
No specific dose adjustments are typically required based on renal or hepatic impairment, but caution is advised in patients with pre-existing electrolyte imbalances or impaired renal function.
### Contraindications
* Congenital megacolon.
* Heart failure.
* Anuria.
* Renal impairment.
* Constriction of the esophagus.
* Abdominal obstruction.
* Acute liver disease.
* Children younger than 5 years (relative contraindication due to risk of toxicity).
* Patients with conditions that increase the risk of electrolyte imbalance or fluid retention.
### Adverse Effects
* Nausea, vomiting, abdominal cramping, bloating, diarrhea.
* Electrolyte imbalances, particularly hyperphosphatemia, hypocalcemia, hypernatremia, and dehydration.
* Rarely, severe complications such as seizures, cardiac arrhythmias, renal failure, and death have been reported, particularly with overuse or in susceptible individuals.
* Rectal irritation.
### Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalance.
* **ACE inhibitors, ARBs, NSAIDs:** Increased risk of hyperkalemia and renal impairment.
* **Calcium and magnesium supplements:** May interfere with absorption.
* **Laxatives:** Concomitant use may potentiate dehydration and electrolyte loss.
### Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., dizziness, dry mouth, decreased urine output, confusion, muscle cramps, arrhythmias).
* Electrolyte panels (phosphate, calcium, sodium, potassium) may be warranted in patients with risk factors or if large or frequent doses are administered.
* Renal function (BUN, creatinine) should be monitored in at-risk patients.
### Clinical Pearls
* This product should not be used for chronic constipation.
* Patients should be advised to drink plenty of clear fluids before and after administration to prevent dehydration.
* The enema should be administered slowly and retained for the recommended duration (typically 2-5 minutes) to ensure efficacy.
* Risk of severe hyperphosphatemia and hypocalcemia is increased in children, elderly patients, and those with renal impairment.
* Cases of acute phosphate nephropathy have been reported.
---
*Please verify this information with the most current prescribing information or official drug compendium, as dosing and safety recommendations can change.*
